Milestone Pharmaceuticals (MIST) EPS (Basic) Growth (3y) (2021 - 2022)
Milestone Pharmaceuticals (MIST) EPS (Basic) Growth (3y) (2021 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn | 64.84% |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn | 18.44% |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 37.21% |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 36.73% |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | -26.87% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 67.51% |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | -38.31% |
| 10 | Milestone Pharmaceuticals | 42.91 Mn | -128.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 12.27% |
| Jun 30, 2022 | 27.32% |
| Dec 31, 2021 | 76.33% |
| Sep 30, 2021 | 74.43% |
| Jun 30, 2021 | 26.02% |
| Mar 31, 2021 | 73.09% |